Carboplatin plus paclitaxel in combination with bevacizumab for the treatment of adenocarcinoma with interstitial lung diseases

By Suzuki   Hirashima   Kobayashi   Okamoto   Matsuura   Tamiya   Morishita   Okafuji   Shiroyama   Morimura   Morita   Kawase  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 480-482

Spandidos Publications

Access to resources Recommend Favorite

Effect of Montelukast, a Cysteinyl Receptor Antagonist, on Myofibroblasts in Interstitial Lung Disease

By Fireman Elizabeth   Schwartz Yehuda   Mann Abraham   Greif Joel  

Journal of Clinical Immunology, Vol. 24, Iss. 4, 2004-07 ,pp. : 418-425

Springer Publishing Company

Access to resources Recommend Favorite

The Regulatory Mechanism of IL-6-dependent Proliferation of Human Myeloma Cells

By Abroun Saeid   Liu Shangqin   Tsuyama Naohiro   Otsuyama Ken-Ichiro   Ishikawa Hideaki   Zheng Xu   Obata Masanori   taniguchi Osamu   Kawano Michio M.   Li Fu-Jun  

Hematology, Vol. 8, Iss. 6, 2003-12 ,pp. : 409-411

Maney Publishing

Access to resources Recommend Favorite

IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor

By Tomita T.  

International Immunology, Vol. 12, Iss. 2, 2000-02 ,pp. : 187-193

Oxford University Press

Access to resources Recommend Favorite

Bacterial lipopolysaccharide induces proliferation of IL-6-dependent plasmacytoma cells by MAPK pathway activation

By Iankov Ianko   Atanasova Ganka   Praskova Maria   Kalenderova Silvia   Petrov Dragomir   Mitev Vanio   Mitov Ivan  

Immunobiology, Vol. 208, Iss. 5, 2004-03 ,pp. : 445-454

Urban & Fischer

Access to resources Recommend Favorite